JUN 22, 2020 7:00 AM PDT

Host Genetics with the new Axiom™ Human Genotyping SARS-CoV-2 Research Array

Speaker
  • Director of Product Marketing, Microarray Genotyping, Thermo Fisher Scientific
    Biography
      Shantanu Kaushikkar is currently the Director of Product Marketing, Genotyping at Thermo Fisher Scientific. He part of the Microarray Leadership Team that is responsible for managing the microarray platform.
      Shantanu started his career in in medical imaging and held various positions at University of Washington in St. Louis, Missouri and Imatron Inc, California. Shantanu has been with Thermo Fisher Scientific for over 18 years in different positions in research and development and in product marketing. During this time he has led teams responsible for managing a diverse product portfolio including genotyping and gene expression microarrays, instruments, software and automation platforms for applications in human disease research and applied markets.
      He holds a master's degree in Biomedical Engineering from Case Western Reserve University, Cleveland Ohio, an M.B.A. from Santa Clara University, Santa Clara, California and a Bachelor of Science degree in Biomedical Engineering from Bombay University in India.

    Abstract
    DATE:  June 22, 2020
    TIME:   7:00am PT, 10:00am ET
     
    This is the first topic in the webinar series on ‘Predictive Genomics for Population & Personalized Health’.
     
    A major challenge for healthcare providers and geneticists is to learn how SARS-CoV-2, the coronavirus that causes the COVID-19 disease, interacts with the human genome and to stratify populations in order to understand disease susceptibility, severity, and outcomes.
     
    For such studies in predictive genomics, we are launching the Applied Biosystems™ Axiom™ Human Genotyping SARS-CoV-2 Research Array with a COVID-19 research module covering various genes and pathways such as ACE2, TMPRSS2, and the NOTCH pathway that are implicated in SARS-CoV-2 host genetics. In addition, the array has a large GWAS module (>820,000 markers) that can serve to conduct association studies to understand the interactions with underlying conditions including COPD, cardiovascular disease, and kidney disease, and to help identify targets that can be treated with drugs.
     
    Learning Objectives:
    • Extend epidemiological research to host genetics to study SARS-CoV-2 infectious disease
    • Review whole genome technology purpose to stratify populations by risk to manage disease
    • Choose a new whole-genome array for SARS-CoV-2 infection research
     
     
    Webinars will be available for unlimited on-demand viewing after live event.
     
    LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.

     


    Show Resources
    You May Also Like
    SEP 10, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 10, 2020 9:00 AM PDT
    Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
    OCT 29, 2020 6:00 AM PDT
    C.E. CREDITS
    OCT 29, 2020 6:00 AM PDT
    Date: October 29, 2020 Time: 6:00am (PDT), 9:00am (EDT), Chronic inflammation can occur as a result of a combination of genetic predispositions and environmental factors. Epigenetic modifica...
    NOV 10, 2020 7:00 AM PST
    C.E. CREDITS
    NOV 10, 2020 7:00 AM PST
    DATE: November 10, 2020 TIME: 7:00am PDT, 10:00am EDT Automation can provide tremendous benefits such as increased pipetting precision and accuracy, productivity, and throughput. Numerous wo...
    NOV 16, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 16, 2020 8:00 AM PST
    Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    FEB 24, 2021 10:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    FEB 24, 2021 10:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    DATE: February 24, 2021 TIME: 10am PST Automated lab instruments such as liquid handlers and cell sorters are increasingly common in all types of laboratories, driving fast results for labor...
    Loading Comments...
    Show Resources
    Attendees
    • See more